S1K Stock Overview
A knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Predictive Oncology Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.60 |
| 52 Week High | US$3.30 |
| 52 Week Low | US$0.59 |
| Beta | 1.21 |
| 1 Month Change | 0% |
| 3 Month Change | -19.46% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -75.70% |
Recent News & Updates
Recent updates
Shareholder Returns
| S1K | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | -3.3% | -2.0% |
| 1Y | n/a | -8.5% | 6.9% |
Return vs Industry: Insufficient data to determine how S1K performed against the German Medical Equipment industry.
Return vs Market: Insufficient data to determine how S1K performed against the German Market.
Price Volatility
| S1K volatility | |
|---|---|
| S1K Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine S1K's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 35 | Raymond Vennare | www.predictive-oncology.com |
Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies. It operates through three segments: Pittsburgh, Birmingham, and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of approximately 150,000 tumor samples and creates proprietary 3D culture models used in drug development.
Predictive Oncology Inc. Fundamentals Summary
| S1K fundamental statistics | |
|---|---|
| Market cap | €4.41m |
| Earnings (TTM) | -€13.15m |
| Revenue (TTM) | €1.42m |
3.1x
P/S Ratio-0.3x
P/E RatioIs S1K overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| S1K income statement (TTM) | |
|---|---|
| Revenue | US$1.48m |
| Cost of Revenue | US$802.85k |
| Gross Profit | US$681.38k |
| Other Expenses | US$14.40m |
| Earnings | -US$13.72m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.06 |
| Gross Margin | 45.91% |
| Net Profit Margin | -924.25% |
| Debt/Equity Ratio | 10.0% |
How did S1K perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 14:49 |
| End of Day Share Price | 2024/10/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Predictive Oncology Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Swayampakula Ramakanth | H.C. Wainwright & Co. |
| Vernon Bernardino | H.C. Wainwright & Co. |